The goal of the study is to compare the efficacy, safety and tolerability of solifenacin plus gabapentin versus solifenacin monotherapy for the treatment of women who are suffering from non-neurogenic ОАВ.
The main questions it aims to answer are:
Does combination of Solifenacin and Gabapentin affect the total score and sub-scores of OABSS in females with non-neurogenic ОАВ ? What medical problems do participants have when taking combination of Solifenacin and gabapentin ?
Overactive bladder symptom score (OABSS) > 5, urgency subscore ≥3, and urge incontinence score≥ 2.
Active urinary tract infection
Neurogenic bladder
History of genitourinary malignancy
Stress urinary incontinence (SUI) as primary diagnosis, or mixed urinary incontinence with predominant SUI